# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-20-021998
Filing Date
2020-10-29
Accepted
2020-10-29 16:25:47
Documents
15
Effectiveness Date
2020-10-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | kmph20201029_defa14a.htm | DEFA14A | 33703
2 |  | slide01.jpg | GRAPHIC | 28585
3 |  | slide02.jpg | GRAPHIC | 132942
4 |  | slide03.jpg | GRAPHIC | 30610
5 |  | slide04.jpg | GRAPHIC | 95413
6 |  | slide05.jpg | GRAPHIC | 70616
7 |  | slide06.jpg | GRAPHIC | 74461
8 |  | slide07.jpg | GRAPHIC | 88654
9 |  | slide08.jpg | GRAPHIC | 88958
10 |  | slide09.jpg | GRAPHIC | 95383
11 |  | slide10.jpg | GRAPHIC | 84844
12 |  | slide11.jpg | GRAPHIC | 75884
13 |  | slide12.jpg | GRAPHIC | 84772
14 |  | slide13.jpg | GRAPHIC | 85337
15 |  | slide14.jpg | GRAPHIC | 28585
| Complete submission text file | 0001437749-20-021998.txt |  | 1500924

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 201272998
SIC: 2834 Pharmaceutical Preparations